Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)
India
· Delayed Price · Currency is INR | Market Cap | 1.48T |
| Revenue (ttm) | 127.42B |
| Net Income (ttm) | 22.72B |
| Shares Out | n/a |
| EPS (ttm) | 67.12 |
| PE Ratio | 65.11 |
| Forward PE | 60.64 |
| Dividend | 35.00 (0.81%) |
| Ex-Dividend Date | Feb 18, 2026 |
| Volume | 231,761 |
| Average Volume | 415,599 |
| Open | 4,191.00 |
| Previous Close | 4,333.30 |
| Day's Range | 4,175.20 - 4,397.50 |
| 52-Week Range | 2,886.45 - 4,470.00 |
| Beta | 0.13 |
| RSI | 67.10 |
| Earnings Date | May 22, 2026 |
About Torrent Pharmaceuticals
Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, urology, gynecology, oncology, gastro-intestinal, nephrology, neuro-psychiatric, cosmo-dermatology, pain management, anti-infective, and miscellaneous, as well as vitamins, minerals, and nutrients. It als... [Read more]
Financial Performance
In fiscal year 2025, Torrent Pharmaceuticals's revenue was 115.16 billion, an increase of 7.35% compared to the previous year's 107.28 billion. Earnings were 19.11 billion, an increase of 15.39%.
Financial StatementsNews
Why Are Shares Of Xeris Biopharma Falling Friday?
Shares of Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) are falling Friday after the company announced a patent infringement lawsuit to protect its drug, Recorlev . Xeris Biopharma Holdings stock is ...
Macquarie initiates coverage on Torrent Pharma with outperform, sets target price for stock at Rs 5,000
Macquarie has initiated coverage on Torrent Pharmaceuticals with an Outperform rating and a target price of Rs 5,000 per share,...
Torrent Pharma shares rally over 5% as Q3 revenue jumps 17.6% YoY to Rs Rs 3,303 crore, net profit up 26.2%
Shares of Torrent Pharmaceuticals rallied over 5% in early trade on February 16, 2026 (IST) after the company reported strong...
Torrent Pharmaceuticals Ltd (BOM:500420) Q3 2026 Earnings Call Highlights: Robust Revenue ...
Torrent Pharmaceuticals Ltd (BOM:500420) Q3 2026 Earnings Call Highlights: Robust Revenue Growth and Strategic Acquisitions
Q3 2026 Torrent Pharmaceuticals Ltd Earnings Call Transcript
Q3 2026 Torrent Pharmaceuticals Ltd Earnings Call Transcript
Torrent Pharmaceuticals Ltd (NSE:TORNTPHARM) Q3 2026 Earnings Report Preview: What To Look For
Torrent Pharmaceuticals Ltd (NSE:TORNTPHARM) Q3 2026 Earnings Report Preview: What To Look For
Torrent Pharmaceuticals in focus as government panel clears key hurdle for Semaglutide tablets
Shares of Torrent Pharmaceuticals are likely to remain in focus after an Indian government-appointed committee accepted the company’s Phase III...
Torrent Pharmaceuticals approves Rs 12,500 crore NCD issuance via private placement
Torrent Pharmaceuticals Limited has approved the issuance of secured, rated, listed and redeemable non-convertible debentures (NCDs) aggregating up to Rs...
Torrent Pharmaceuticals Ltd (BOM:500420) Q2 2026 Earnings Call Highlights: Strong Revenue ...
Torrent Pharmaceuticals Ltd (BOM:500420) Q2 2026 Earnings Call Highlights: Strong Revenue Growth Amidst Market Challenges
Torrent Pharmaceuticals shares rise over 4% today after strong Q2 earnings
Shares of Torrent Pharmaceuticals Limited surged over 4% on Monday, November 10, following the company’s robust September quarter results for...
Q2 2026 Torrent Pharmaceuticals Ltd Earnings Call Transcript
Q2 2026 Torrent Pharmaceuticals Ltd Earnings Call Transcript
Cybercrooks create fake website of pharma major to dupe investors
Ahmedabad: Cyber fraudsters cheated several people allegedly by creating fake websites in the name of Torrent Pharmaceuticals, one of the country's le.
Torrent Pharma to acquire 26% stake in Torrent Urja 27 for renewable energy project in Gujarat
Torrent Pharmaceuticals Limited today announced that it has entered into a Share Subscription and Shareholders’ Agreement to subscribe to 26% equity shares of Torrent Urja 27 Private Limited. The inve...
Torrent Pharma’s Vizag plant clears USFDA inspection with zero observations
Torrent Pharmaceuticals has announced the successful completion of a USFDA inspection at its manufacturing facility located in Visakhapatnam, Andhra Pradesh. The inspection was conducted between July ...
Torrent Pharma Q1 net profit rises 20% on broad-based growth
Torrent Pharmaceuticals reported a robust 20% increase in net profit, reaching Rs 548 crore for Q1 FY26, fueled by strong performances in India, the US, and Brazil. Consolidated revenue grew by 11% to...
Torrent Pharma shares jump 2% after Q1 profit jumps 20% YoY; US and India drive growth
Shares of Torrent Pharmaceuticals Ltd climbed nearly 2% to ₹3,695.40 on the NSE on Tuesday, after the company posted a 20% year-on-year increase in consolidated net profit to ₹548 crore for the June q...
Citi bullish on Torrent Pharma, sees 21% upside as margins hold strong and US recovery expected
Citi has maintained a Buy rating on Torrent Pharmaceuticals, raising its target price to ₹4,380, implying an upside of approximately 20.7% from the current market price of ₹3,630.00. The brokerage not...
Stocks to watch on July 29: Torrent Pharma, IndusInd Bank, GAIL, BEL, Radico Khaitan, IEX, United Spirits in focus after fresh brokerage calls
A fresh wave of brokerage reports has put the spotlight on several stocks that could see action on July 29. From upgrades to earnings commentary and new initiations, key developments have come in for ...
Torrent Pharmaceuticals to acquire additional 2.41% stake in JB Chemicals for Rs 620 crore
Torrent Pharmaceuticals Limited has announced that it will acquire up to 2.41% of the equity share capital of JB Chemicals & Pharmaceuticals Limited (JB Chemicals) for a total consideration of approxi...
Stocks to watch on brokerages today, June 30: Uno Minda, Torrent Pharma, RBL Bank, Reliance Industries and more
Leading global brokerages have released updated views on several major Indian stocks, adjusting ratings and target prices based on recent developments and performance trends. Here’s a round-up of the ...
Torrent Pharmaceuticals shares rise over 3% today; Company announces Rs 300 crore commercial paper issuance
Shares of Torrent Pharmaceuticals surged over 3% during Friday’s session, following the company’s announcement of issuing commercial papers worth Rs 300 crore. The stock climbed 3.08% to trade at Rs 3...
Pharma stocks rally: Glaxo surges 7%, Torrent gains after Q4; Gland steady post mixed results
Pharma stocks were trading firmly in the green on Tuesday morning, with GlaxoSmithKline Pharmaceuticals leading the charge—rising 7.4% to ₹2,992.80 as of 10:05 AM. The broader sector saw widespread bu...
Torrent Pharma shares jump 3% as Q4 EBITDA rises 9.2% YoY to Rs 964 crore
Torrent Pharmaceuticals shares jumped over 3% in morning trade following robust Q4FY24 earnings. As of 9:27 AM, the shares were trading 3.17% higher at Rs 3,344.20, The company reported a net profit o...
Torrent Pharma share price: Nomura sees 11% upside, maintains neutral after Q4 miss due to one-off
Nomura has maintained a neutral rating on Torrent Pharmaceuticals, with a target price of ₹3,580, suggesting a modest upside of nearly 11% from the current market price of ₹3,233.10. The brokerage fla...
Torrent Pharma share price: Nuvama expects 16% upside, cites India, US growth and semaglutide launches
Nuvama Institutional Equities has maintained its buy rating on Torrent Pharmaceuticals with a target price of ₹3,760, citing steady Q4 performance and strong growth prospects across geographies. While...